Cardiovascular Revascularization Medicine
Volume 10, Issue 1 , Pages 55-57 , January 2009

Extremely late drug-eluting stent thrombosis: 2037 days after deployment

  • Jamie Layland

      Affiliations

    • Corresponding Author InformationCorresponding author. Cardiac Investigation Unit, St Vincent's Hospital Melbourne, 41 Victoria Parade, P.O. Box 2900, Fitzroy, VIC 3065, Australia. Tel.: +61 3 9288 2211; fax: +61 3 9288 4422.
    • ,
  • Christine Jellis
    • ,
  • Robert Whitbourn

Received 1 May 2008 ,Accepted 2 May 2008.

References 

  1. Stone GW, Moses JW, Ellis SG, Schofer J, Dawkins KD, Morice MC, et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med. 2007;356:998–1008
  2. Daemen J, Wenaweser P, Tsuchida K, Abrecht L, Vaina S, Morger C, et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice. Lancet. 2007;369:667–678
  3. Windecker S, Meier B. Late coronary stent thrombosis. Circulation. 2007;116:1952–1965
  4. Li N, Astudillo R, Ivert T, Hjemdahl P. Biphasic pro-thrombotic and inflammatory responses after coronary artery bypass surgery. J Thromb Haemost. 2003;1:470–476

PII: S1553-8389(08)00209-1

doi: 10.1016/j.carrev.2008.05.001

Cardiovascular Revascularization Medicine
Volume 10, Issue 1 , Pages 55-57 , January 2009

Article Tools

* Image Usage & Resolution